MetaCap

Bone Biologics (BBLG) vs Decoy Therapeutics (DCOY)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Decoy Therapeutics is the larger company by market cap ($3.5 million vs $1.3 million), about 2.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BBLG-3.77%DCOY-5.59%
+0%-3%-6%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BBLG versus DCOY key metrics
MetricBBLGDCOY
Share price$0.4737$1.47
Market cap$1.31M$3.51M
1-day change+0.98%-3.28%
P/E ratio (TTM)—0.12
EPS (TTM)$-1.37$12.74
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$2.76$55.92
52-week low$0.428$1.46
Distance from 52-week high-82.83%-97.37%
Analyst consensusnonestrong_buy
Avg. price target upside+2475.47%+104.08%
Average volume378.20K2.17M
Shares outstanding2.76M2.39M
Employees211
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Decoy Therapeutics is about 2.7 times larger than Bone Biologics by market value ($3.51M vs $1.31M).

About Bone Biologics

BBLG stock →

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration.

Health Care · Industrial Specialties · 2 employees

About Decoy Therapeutics

DCOY stock →

Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company.

Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees

BBLG vs DCOY FAQ

Which is bigger, Bone Biologics or Decoy Therapeutics?

Decoy Therapeutics (DCOY) is larger, with a market capitalization of $3.51M compared with $1.31M for Bone Biologics (BBLG).

Are Bone Biologics and Decoy Therapeutics in the same industry?

Both are in the Health Care sector, but in different industries: Industrial Specialties for Bone Biologics and Biotechnology: Pharmaceutical Preparations for Decoy Therapeutics.

More comparisons